Satellos Bioscience Financial Overview
Satellos Bioscience's market cap is currently $91.81M. The company's EPS TTM is $-0.030567012000000005; its P/E ratio is ―; Satellos Bioscience is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
